Literature DB >> 6105169

Necrotizing vasculitis.

W M Sams.   

Abstract

Necrotizing vasculitis is a term used to describe vessel wall necrosis due to neutrophil infiltration. Current evidence strongly suggests that these cells are responding to elaboration of chemotactic factors of the complement cascade released at the site of deposition of immune complexes in the vessel wall. The antibody is usually IgG or IgM (and rarely IgA), but the only antigens identified with even a minimum certainty are the streptococcal M protein, the hepatitis B surface antigen, and Mycobacterium tuberculosis. Vessels may be involved, leading to specific signs or symptoms, in a wide range of organs, but with those of the skin, kidney, joints, and gastrointestinal tract leading the list. Why vessels of different sizes or location become involved in individual patients is unknown. Therapy with nontoxic drugs, such as antihistamines or salicylates, is indicated when the disease is mild, but vital organ involvement may necessitate therapy with systemic corticosteroids and/or cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105169     DOI: 10.1016/s0190-9622(80)80215-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Ileitis terminalis in a patient with Henoch-Schönlein purpura.

Authors:  N Ortego-Centeno; J L Callejas-Rubio; J G López-Mañas; E Troncoso-García; J de la Higuera Torres-Puchol
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Epidermal expression of the calcium binding surface antigen 27E10 in inflammatory skin diseases.

Authors:  M Kunz; J Roth; C Sorg; G Kolde
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

Authors:  C F Moyer; J D Strandberg; C L Reinisch
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

Review 4.  Pulmonary vasculitis.

Authors:  D B Chandler; J D Fulmer
Journal:  Lung       Date:  1985       Impact factor: 2.584

5.  Henoch-Schönlein purpura with ileitis terminalis.

Authors:  W A Scherbaum; R Kaufmann; U Vogel; G Adler
Journal:  Clin Investig       Date:  1993-07

6.  Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.

Authors:  G F Springer; S M Murthy; P R Desai; W A Fry; H Tegtmeyer; E F Scanlon
Journal:  Klin Wochenschr       Date:  1982-02-01

7.  Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis.

Authors:  Y Miyachi; K Yanase; S Imamura; Y Niwa
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Vasculitis.

Authors:  R C Ongley
Journal:  Can Fam Physician       Date:  1987-10       Impact factor: 3.275

Review 9.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

10.  Epstein-Barr virus-related cutaneous necrotizing vasculitis in a girl heterozygous for factor V Leiden.

Authors:  Cristina Guerriero; Gaia Moretta; Giulia Bersani; Piero Valentini; Antonio Gatto; Donato Rigante
Journal:  J Dermatol Case Rep       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.